Today: 14 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

UnitedHealth shares rose 0.8% to $338.94 in late-morning trading Monday after Barclays raised its price target to $391 and reiterated an Overweight rating. Investors are watching ahead of Jan. 27, when UnitedHealth will report 2025 results and 2026 guidance. Scrutiny remains on medical-cost trends, operational review progress, and ongoing Justice Department investigations into Medicare Advantage billing.
5 January 2026
·····
Goldman Sachs stock hits a record high as Venezuela shock lifts Dow; payrolls and earnings in focus

Goldman Sachs stock hits a record high as Venezuela shock lifts Dow; payrolls and earnings in focus

Goldman Sachs shares hit a record high Monday, rising 4.3% to $953.61 after a U.S. military strike captured Venezuelan President Nicolas Maduro. The move lifted the Dow to an all-time high as financial and energy stocks rallied. Oil prices steadied near $61 a barrel. Traders are watching Friday’s U.S. jobs report and Goldman’s January 15 earnings for further direction.
5 January 2026
··
Rocket Lab stock slips after rally as insider sale filing surfaces; Neutron timing in focus

Rocket Lab stock slips after rally as insider sale filing surfaces; Neutron timing in focus

Rocket Lab shares fell 0.7% to $75.43 by late Monday morning after a recent surge driven by an $816 million U.S. Space Development Agency satellite contract. A Form 144 filing showed COO Frank Klein plans to sell up to 100,000 shares. Cantor Fitzgerald reiterated an Overweight rating and a $72 target. Rocket Lab is expected to report earnings around Feb. 26.
5 January 2026
··
Boeing stock edges up as Venezuela shock lifts defense names; BA traders eye payrolls next

Boeing stock edges up as Venezuela shock lifts defense names; BA traders eye payrolls next

Boeing shares rose 0.7% to $229.33 by 11:23 a.m. ET Monday as U.S. defense stocks gained after a U.S. strike in Venezuela and President Trump announced the capture of Venezuelan President Nicolas Maduro. About 3.1 million Boeing shares traded, below the daily average. Investors are watching Friday’s U.S. jobs report and Boeing’s upcoming results for signs of cash flow and delivery momentum.
5 January 2026
··
Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. shelves and stokes obesity-drug pricing fears

Eli Lilly stock slides as Novo’s Wegovy pill hits U.S. shelves and stokes obesity-drug pricing fears

Eli Lilly shares dropped 3.4% to $1,043.14 after Novo Nordisk launched U.S. sales of an oral Wegovy weight-loss pill starting at $149 a month. Novo’s move intensified focus on pricing in the obesity drug market. The Health Care Select Sector SPDR ETF fell 1.3%, while Novo Nordisk shares rose 2.9%. Investors are awaiting Lilly’s next earnings update on February 4.
5 January 2026
···
Sandisk stock rises as AI memory shortage talk lifts SNDK; earnings date looms

Sandisk stock rises as AI memory shortage talk lifts SNDK; earnings date looms

Sandisk Corp shares rose 1.4% to $279.00 in Monday morning trading, with about 4.8 million shares exchanged. The move follows surging demand and tight supply for memory chips used in AI data centers, pushing some prices to more than double since February 2025. Samsung called the shortage “unprecedented.” Sandisk reports fiscal Q2 results on Jan. 29.
5 January 2026
···
Oracle stock holds steady after Jefferies sticks with $400 target as Wall Street eyes jobs data

Oracle stock holds steady after Jefferies sticks with $400 target as Wall Street eyes jobs data

Oracle shares were flat Monday after Jefferies reaffirmed a buy rating and $400 target, with the stock trading near $196. Investors remain wary after Oracle raised its 2026 capital spending estimate by $15 billion in December, citing AI data-center expansion. The company reported $16.1 billion in Q2 revenue and a $523 billion backlog. Key macro data, including ISM Services and U.S. payrolls, are due later this week.
5 January 2026
·
Intel stock lifts on Melius upgrade as traders brace for Intel’s CES Panther Lake reveal

Intel stock lifts on Melius upgrade as traders brace for Intel’s CES Panther Lake reveal

Intel shares rose 0.7% to $39.67 Monday morning after Melius Research upgraded the stock to “buy” and set a $50 target ahead of the company’s CES event. Senior VP Jim Johnson will unveil the Core Ultra Series 3 “Panther Lake” processors at 6 p.m. ET. Semiconductor stocks broadly gained, with the iShares Semiconductor ETF up 2%. Investors await product details and Intel’s Jan. 29 earnings report.
5 January 2026
Netflix stock edges higher as CFRA downgrades on Warner Bros. deal risk

Netflix stock edges higher as CFRA downgrades on Warner Bros. deal risk

Netflix shares rose about 1% to $91.90 Monday despite CFRA downgrading the stock to Hold and cutting its price target to $100, citing risks tied to the planned $82.7 billion Warner Bros. Discovery deal. CFRA warned the deal could face prolonged U.S. and EU regulatory scrutiny and possible required divestitures. Investors await Netflix’s Jan. 20 results for details on financing and deal terms.
5 January 2026
·
Nvidia stock edges up as CES 2026 puts AI chip demand back in the spotlight

Nvidia stock edges up as CES 2026 puts AI chip demand back in the spotlight

Nvidia shares rose 0.7% to $190.12 Monday, trading near a session high ahead of CEO Jensen Huang’s CES appearance. Foxconn reported a 22% jump in Q4 revenue on strong AI demand, boosting chip stocks. AMD gained 0.7%, Broadcom fell 2.1%, and Arm Holdings rose 5.3%. U.S. manufacturing contracted for a tenth month, with inflation data in focus before Friday’s jobs report.
5 January 2026
···
Meta stock rises in early trade as AI lawsuits and inflation worries hang over Big Tech

Meta stock rises in early trade as AI lawsuits and inflation worries hang over Big Tech

Meta shares rose 1.2% to $658.45 in early New York trading Monday, rebounding with tech as U.S. benchmarks climbed. The S&P 500 and Nasdaq each gained about 0.6%. Investors are watching Friday’s U.S. jobs report and upcoming inflation data for signals on interest rates. Meta traded between $646.79 and $660.10, with 2.1 million shares changing hands.
5 January 2026
··
Bitcoin price nears $94,000 as Strategy buy boosts Coinbase and crypto stocks

Bitcoin price nears $94,000 as Strategy buy boosts Coinbase and crypto stocks

Bitcoin rose 2.4% to $93,501 by 9:59 a.m. EST Monday, after Strategy Inc disclosed a $116 million bitcoin purchase in an SEC filing. U.S.-listed crypto stocks rallied, with Coinbase up 6.6% and Strategy gaining 5.7%. Investors monitored fallout from the U.S. capture of Venezuela’s Nicolas Maduro and awaited ISM factory data at 10 a.m. ET. Ether traded 1% higher at $3,167.
5 January 2026
·····
1 … 389 390 391 392 393 … 704

Stock Market Today

  • Becton Dickinson (BDX) Stock Seen Undervalued Amid Recent Price Declines
    March 14, 2026, 1:04 PM EDT. Becton Dickinson's shares dropped 4.6% last week and 18.3% year to date, sparking questions about its market valuation. A Discounted Cash Flow (DCF) analysis estimates an intrinsic value of $218.65 per share, indicating the stock is trading roughly 27.1% below fair value. The company's latest free cash flow stands at $2.60 billion, with analyst forecasts projecting growth to $3.73 billion by 2030. Becton Dickinson's price-to-earnings (P/E) ratio of 25.83 is near the Medical Equipment industry average, reflecting current investor expectations. These metrics suggest a potential buying opportunity for long-term investors watching shifts in healthcare supplier valuations.
Go toTop